These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1769680)

  • 1. Methoxyphenyl maleamic acid augments the activity of cytotoxic drugs against murine tumours.
    Indap MA; Ambaye RY
    Indian J Cancer; 1991 Mar; 28(1):22-6. PubMed ID: 1769680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of 5-fluorouracil in combination with methoxyphenyl maleamic acid in murine tumors.
    Indap MA; Ambaye RY
    J Postgrad Med; 1991 Oct; 37(4):211-5. PubMed ID: 1841970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
    Li LH; DeKoning TF; Wallace TL
    Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
    Borden EC; Sidky YA; Hatcher JF; Bryan GT
    Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental combination chemotherapy of pirarubicin with various antitumor drugs against P388 murine leukemia.
    Izumi H; Hirano S; Matsushita Y; Iguchi H; Tone H; Takeuchi T
    Cancer Biochem Biophys; 1994 Sep; 14(2):137-49. PubMed ID: 7889494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J; Robak T
    Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of antitumor activity of pirarubicin by chlorpromazine in mice bearing doxorubicin-resistant P388 leukemia.
    Shibata H; Maekawa I; Furusawa S; Kawauchi H; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):359-62. PubMed ID: 2093213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL; Roberts BJ; Howard CT; Leopold WR
    Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoimmunotherapy of B 16 melanoma and P388 leukemia with cyclophosphamide and pyrimidinones.
    Li LH; Johnson MA; Moeller RB; Wallace TL
    Cancer Res; 1984 Jul; 44(7):2841-7. PubMed ID: 6722813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.
    Novotny L; Rauko P; Liska J; Elford HL; Szekeres T
    Cancer Lett; 2006 Feb; 233(1):178-84. PubMed ID: 15885888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T; Oh-Hara T; Sudo Y; Naito M
    Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation by vitamin A of the action of anticancer agents against murine tumors.
    Nakagawa M; Yamaguchi T; Ueda H; Shiraishi N; Komiyama S; Akiyama S; Ogata J; Kuwano M
    Jpn J Cancer Res; 1985 Sep; 76(9):887-94. PubMed ID: 3932288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-nitros ourea in a murine tumor system.
    Yamaguchi T; Nakagawa M; Hidaka K; Yoshida T; Sasaki T; Akiyama S; Kuwano M
    Jpn J Cancer Res; 1985 Oct; 76(10):1021-6. PubMed ID: 3935620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of resistance to vincristine in P388 leukemia by various polycyclic clinical drugs, with a special emphasis on quinacrine.
    Inaba M; Maruyama E
    Cancer Res; 1988 Apr; 48(8):2064-7. PubMed ID: 3349478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of N-(o-methoxyphenyl)-maleimide on 5-fluorouracil cytotoxicity in Ehrlich (ascites) carcinoma.
    Ambaye RY; Indap MA
    Cancer Lett; 1991 Apr; 57(1):21-6. PubMed ID: 1902758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effect of cyclophosphamide and extracts of Crotalaria and Senecio plants on experimental tumours.
    Indap MA; Gokhale SV
    Indian J Physiol Pharmacol; 1986; 30(2):182-6. PubMed ID: 3818046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inability of amphotericin B(Fungizone) or of sodium deoxycholate to alter natural drug resistance or sensitivity of transplanted murine leukemias.
    Ganu UK; Khandalekar DD; Gokhale SV
    Indian J Physiol Pharmacol; 1984; 28(1):21-6. PubMed ID: 6490126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone does not enhance antileukemic activity of cladribine in mice with leukemias L1210 and P388.
    Robak T; Szmigielska A
    Neoplasma; 2000; 47(3):168-71. PubMed ID: 11043840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined effect of CDDP with various types of antitumor drugs against P 388 leukemia].
    Uchida T; Nishikawa K; Shibasaki C; Okamoto K; Arakawa M; Ekimoto H; Takahashi K
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2275-82. PubMed ID: 2735770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
    Cantrell JE; Green D; Schein PS
    Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.